Stock info Alkermes | Filter  Basic-Info

Stock: Alkermes (US broad)

Last Price 26.97 Max Price 33.63
Min Price 23.71 1 Year return 15.95
Sector Health Care Subsector Biotechnology
Annual report 2017

Loading...

Contact info:Street: Connaught House,1 Burlington RoadZip Code: 4City: DublinCountry: USAPhone: 353 1 772 8000Website: www.alkermes.comCEO: Mr. Richard F. PopsCFO: Mr. James M. Frates

Sector Review Alkermes

Loading...
Year Turnover Total sector Market share
2019 1,171 141,925 0.83 %
2020 1,039 170,231 0.61 %
2021 1,174 252,886 0.46 %
2022 1,112 238,500 0.47 %
2023 0 0 0.00 %

Advice Alkermes

No Records Found




News Alkermes

No Records Found

Annual reports Alkermes

2017 2018 2019 2020 2021

Profile Alkermes

Alkermes


Past year was a negative year for Alkermes investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 27 percent. Over the period from December 2011 till December 2016 the stock rose on average 231 percent. Alkermes's revenues between 2011 and 2015 were very volatile and moved between 389,98 million dollars and 628,34 million dollars. Alkermes's net incomes between 2011 and 2015 were very volatile through the time and moved between -45,54 million dollars and -227,16 million dollars.

Alkermes's headquarter is based in Dublin. Alkermes's core business is the pharmaceutical sector. Mr. Richard F. Pops is the CEO of the company. Alkermes' CFO is Mr. James M. Frates. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The American company didn't pay out any dividends (in the past 5 years).

At the end of 2015 around 1300 thousand people were on Alkermes' payroll.

Healthy financed: not so much debt Alkermes

At the end of 2015 the pharmaceutical company's balance sheet equaled 1,86 billion dollars. 541,46 million dollars (29,18 percent of the total balance sheet) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio -37. So the stock' value was -37 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 11,42 billion dollars. At the end of 2015 the American company had around 150,7 million stocks listed on the exchanges.

At this page you find all Alkermes's financial reports. More information about Alkermes can be found it's website. .


Results Alkermes

Results
2015
2016
2017
2018
2019
2020
Revenue
628
746
903
1,094
1,171
1,039
Costs
856
954
1,061
1,234
1,368
1,150
Profit
-227
-208
-158
-139
-197
-111
Margin of profit
-36.15
-27.95
-17.48
-12.73
-16.79
-10.67
ROI
-17.28
-17.23
-13.13
-11.89
-18.11
-10.39

Balance Alkermes

Balance
2015
2016
2017
2018
2019
2020
Equity
1,314
1,209
1,203
1,171
1,085
1,067
Debt
541
517
594
654
720
883
Total assets
1,856
1,726
1,797
1,825
1,805
1,950
Solvency
70.82
70.06
66.93
64.18
60.12
54.72
Cash
535
497
434
539
535
635
Cashflow
-40
-64
19
99
72
83
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-0.07
-0.12
0.03
0.15
0.10
0.09

Details Alkermes

Details
2016
2017
2018
2019
2020
Price
79.38
55.58
54.73
29.51
20.40
Eps
-1.38
-1.03
-0.90
-1.25
-0.70
Price/earnings-ratio
-57.52
-53.96
-60.81
-23.61
-38.53
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
7.93
7.81
7.52
6.88
6.70
Market to book
0.10
0.14
0.14
0.23
0.25
Cashflow per stock
-0.42
0.12
0.64
0.46
0.52
Stocks
152
154
156
158
159
Market Cap
12.099.93
8.559.85
8.524.58
4.656.06
4.292.57

Dividend Alkermes


Price info Alkermes

Date
Price
22 Mar 2024
26.97
18 Mar 2024
28.75
15 Mar 2024
28.88
12 Mar 2024
28.60
11 Mar 2024
29.25
09 Mar 2024
29.25
07 Mar 2024
28.94
01 Mar 2024
29.69
29 Feb 2024
29.80
27 Feb 2024
30.04
22 Feb 2024
29.18
21 Feb 2024
30.39
20 Feb 2024
32.18
15 Feb 2024
27.99
14 Feb 2024
27.23
13 Feb 2024
28.52
09 Feb 2024
26.77
08 Feb 2024
26.70
07 Feb 2024
27.04
06 Feb 2024
26.40
05 Feb 2024
26.74
01 Feb 2024
27.05
31 Jan 2024
27.41
30 Jan 2024
28.31
27 Jan 2024
27.74
25 Jan 2024
28.12
24 Jan 2024
28.54
23 Jan 2024
28.46
16 Jan 2024
28.20
11 Jan 2024
28.15